Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has repurchased 1,000,000 ordinary shares for approximately £12.1 million as part of its $250 million share buyback program. These repurchased shares are intended for cancellation. Since the program's inception, Hikma has bought back a total of 2,326,376 ordinary shares for £29.0 million. Following these transactions, the company holds 12,833,233 ordinary shares in treasury, with 219,560,077 ordinary shares in issue, representing the total number of voting rights.

Disclaimer*

UK 100

Latest directors dealings